Core Strategies Content Hub FDA Gives Go-Ahead for Pfizer’s Vaccine for Kids 5–11, Waiting on CDC Approval By Karrie GordonOctober 29, 2021
Core Strategies Content Hub Tech Earnings Help Maintain Momentum in Growth Stock ETFs By Max ChenOctober 27, 2021
Core Strategies Content Hub Growth ETFs Rally as Earnings Season Picks Up Pace By Max ChenOctober 25, 2021
Core Strategies Content Hub Growth ETFs Maintain Momentum as Markets Wobble By Max ChenOctober 21, 2021
Core Strategies Content Hub ESG Investing a Focus of Executives at Milken Conference By Karrie GordonOctober 19, 2021
Core Strategies Content Hub Growth ETFs Shake Off China Concerns as Investors Turn to Q3 Earnings By Max ChenOctober 18, 2021
Core Strategies Content Hub Biden Administration Pushing for ESG Inclusion in Retirement Funds By Karrie GordonOctober 15, 2021
Core Strategies Content Hub Tax-Free Municipal Bond ETFs on the Rise By Karrie GordonOctober 13, 2021
Core Strategies Content Hub Growth ETFs Try to Hold On as Investors Look to the Earnings Season By Max ChenOctober 11, 2021
Core Strategies Content Hub How the SEC Unintentionally Locked Retail Investors in OTC Markets By Karrie GordonOctober 11, 2021
Core Strategies Content Hub Growth Stock ETFs Climb Over the Wall of Worry By Max ChenOctober 8, 2021
Core Strategies Content Hub How the Infrastructure Bill Could Benefit Municipal Bonds By Karrie GordonOctober 5, 2021
Core Strategies Content Hub American Century Investments Practices Its “Prosper With Purpose” Principles By Karrie GordonSeptember 29, 2021
Core Strategies Content Hub Matt Lewis: Why Advisors Shouldn’t Be Scared to Use Smaller ETFs By Lara CriggerSeptember 28, 2021
